- Trans femoral Approach
- Trans apical Approach
- Trans aortic Approach
Transcatheter Aortic Valve Replacement (TAVR) Devices Market size was valued at USD 11.9 billion in 2023, growing at a CAGR of 21.1% from 2024-2030. TAVR devices Market is a new technology that has recently been shown to improve survival and quality of life in patients with severe symptomatic aortic stenosis who are not surgical candidates. The development and design of transcatheter valves has been ongoing for the past 20 years and TAVR has been approved recently by GDA for treatment of aortic stenosis in patients who are not surgical candidates. Transcatheter Aortic Valve Replacement (TAVR) Devices Market players are focusing on R&D investments to develop and launch various new and technologically advanced devices for making heart valve procedures safer and more effective and strengthening their positions in the market. For instance, transcatheter aortic valve replacement or transcatheter aortic valve implantation has become a novel procedure for patients who are considered at high risk for standard valve replacement therapy. Apart from this, companies also focus on mergers and acquisitions to enhance their market share.
Transcatheter Aortic Valve Replacement (TAVR) Devices Market Key Developments:
- In 2016, Edwards Lifesciences Corporation agreed to acquire Valtech Cardio Ltd., for trans catheter repair of mitral and tricuspid valves. The revised report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.
Transcatheter Aortic Valve Replacement Tavr Devices Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
21.1%
Largest Market
North America
Fastest Growing Market
Asia pacific
North-America Got Significant Share
Transcatheter Aortic Valve Replacement (TAVR) Devices Market Regional Analysis
Geographically, global Transcatheter Aortic Valve Replacement (TAVR) Devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America market is dominating among all regions. Over five million people in U.S. are diagnosed with heart valve disease each year. Europe Transcatheter Aortic Valve Replacement (TAVR) Devices market for expected to grow at significant rate due to technological advancements, increase in awareness and acceptance of novel replacement devices for cardiac disorders. Emerging economies of Asia-Pacific region such as China and India expected to show significant growth in the market due to medical tourism, increasing patients with heart diseases and significant changing in lifestyle
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Transcatheter Aortic Valve Replacement Tavr Devices Market Segmentation
Type of Procedure
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East and Africa
Frequently Asked Questions
The thetranscatheter aortic valve replacement (TAVR) devices market size was valued at USD 11.9 billion in 2023.
Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), Abbot Laboratories (U.S.)Medtronic Plc. (U.S), Jena Valve Technology, Inc. (U.S)
North America is the fastest-growing region for transcatheter aortic valve replacement (TAVR) devices
| 1. Executive Summary |
| 2. Global Transcatheter Aortic Valve Replacement (TAVR) Market Introduction |
| 2.1. Global Transcatheter Aortic Valve Replacement (TAVR) Market Taxonomy |
| 2.2. Global Transcatheter Aortic Valve Replacement (TAVR) Market Definitions |
| 2.2.1. By Procedure |
| 2.2.2. By Region |
| 3. Global Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Transcatheter Aortic Valve Replacement (TAVR) Market Dynamic Factors Impact Analysis |
| 3.6. Impact of COVID 19 on The Market |
| 3.7. Three Forecast Scenarios - Pessimistic, Conservative, and Opportunistic |
| 3.8. Mapping Market Player’s Activities |
| 3.9. Recent Key Developments |
| 3.10. Financial Status of the Market Players |
| 3.11. Recent Acquisitions, Collaborations, and Mergers |
| 4. Global Transcatheter Aortic Valve Replacement (TAVR) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Transcatheter Aortic Valve Replacement (TAVR) Market Forecast, By Procedure, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 5.1. Transfemoral |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Transapical |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Transaortic |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Subclavian |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Global Transcatheter Aortic Valve Replacement (TAVR) Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 6.1. North America |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Europe |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Asia-Pacific |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Latin America |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Middle East and Africa |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Global Transcatheter Aortic Valve Replacement (TAVR) Market - Opportunity Analysis Index, By Procedure, and Region, 2024 - 2030 |
| 7. North America Transcatheter Aortic Valve Replacement (TAVR) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 7.1. Procedure Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 7.1.1. Transfemoral |
| 7.1.2. Transapical |
| 7.1.3. Transaortic |
| 7.1.4. Subclavian |
| 7.1.5. Others |
| 7.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
| 7.2.1. U.S. |
| 7.2.2. Canada |
| 7.3. North America Transcatheter Aortic Valve Replacement (TAVR) Market - Opportunity Analysis Index, By Procedure, and Country, 2024 - 2030 |
| 7.4. North America Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics Trends |
| 8. Europe Transcatheter Aortic Valve Replacement (TAVR) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 8.1. Procedure Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Transfemoral |
| 8.1.2. Transapical |
| 8.1.3. Transaortic |
| 8.1.4. Subclavian |
| 8.1.5. Others |
| 8.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
| 8.2.1. Germany |
| 8.2.2. UK |
| 8.2.3. France |
| 8.2.4. Italy |
| 8.2.5. Spain |
| 8.2.6. Rest of Europe |
| 8.3. Europe Transcatheter Aortic Valve Replacement (TAVR) Market - Opportunity Analysis Index, By Procedure, and Country, 2024 - 2030 |
| 8.4. Europe Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics Trends |
| 9. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 9.1. Procedure Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Transfemoral |
| 9.1.2. Transapical |
| 9.1.3. Transaortic |
| 9.1.4. Subclavian |
| 9.1.5. Others |
| 9.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Japan |
| 9.2.2. China |
| 9.2.3. India |
| 9.2.4. ASEAN |
| 9.2.5. Rest of Asia-Pacific |
| 9.3. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market - Opportunity Analysis Index, By Procedure, and Country, 2024 - 2030 |
| 9.4. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics Trends |
| 10. Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 10.1. Procedure Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Transfemoral |
| 10.1.2. Transapical |
| 10.1.3. Transaortic |
| 10.1.4. Subclavian |
| 10.1.5. Others |
| 10.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Brazil |
| 10.2.2. Argentina |
| 10.2.3. Rest of Latin America |
| 10.3. Latin America Transcatheter Aortic Valve Replacement (TAVR) Market - Opportunity Analysis Index, By Procedure, and Country, 2024 - 2030 |
| 10.4. Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics Trends |
| 11. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Million) |
| 11.1. Procedure Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Transfemoral |
| 11.1.2. Transapical |
| 11.1.3. Transaortic |
| 11.1.4. Subclavian |
| 11.1.5. Others |
| 11.2. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Saudi Arabia |
| 11.2.2. GCC Countries |
| 11.2.3. South Africa |
| 11.2.4. Rest of MEA |
| 11.3. MEA Transcatheter Aortic Valve Replacement (TAVR) Market - Opportunity Analysis Index, By Procedure, and Country, 2024 - 2030 |
| 11.4. MEA Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics Trends |
| 12. Competition Landscape |
| 12.1. Strategic Dashboard of Top Market Players |
| 12.2. Company Profiles (Introduction, Financial Analysis, Procedure Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 12.2.1. Medtronic plc |
| 12.2.2. Boston Scientific Corporation |
| 12.2.3. Edwards Lifesciences Corporation |
| 12.2.4. Abbott Laboratories |
| 12.2.5. Bracco |
| 12.2.6. JenaValve Technology |
| 12.2.7. Meril Life Sciences |
| 13. Research Methodology |
| 14. Key Assumptions and Acronyms |
- Edwards Lifesciences Corporation (U.S.)
- Boston Scientific Corporation (U.S.)
- Abbot Laboratories (U.S.)
- Medtronic Plc. (U.S)
- Jena Valve Technology, Inc. (U.S)
- Bracco SpA. (Italy)
- Direct Flow medical, Inc. (U.S)
- Meril Life Sciences Pvt. Ltd. (India)